The global contrast media injectors market was valued at $1,405.90 million in 2020, and is estimated to reach $2,608.20 million by 2030, growing at a CAGR of 8.00% from 2021 to 2030.
Contrast injectors are medical devices that are used to inject radio-opaque contrast media into the body to improve the visibility of tissues during a medical imaging treatment. With increasing technological sophistications every year, these contrast injectors have evolved from manual injectors with manifolds and stop-cocks to automated ones, delivering more precision and advantages. Autoinjectors are automated versions of injectors. In cardiac imaging, automated contrast media injectors are utilized to increase patient safety and image quality. These devices regulate contrast dosage, record how much is used, speed up injections to keep up with fast CT scanners, and warn of potential risks such as air embolisms or extravasations.
Major factors driving the growth of the contrast media injectors market include rising demand for minimally invasive surgical procedures. These devices assist the surgeons to accurately insert contrast agents with minimum human errors, thus increasing the accuracy and efficiency of surgical procedures. On the other hand, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market during the forecast period. Moreover, increasing prevalence of cancer and CVD is also responsible to boost the market growth.
Increasing investments, funds, new product launches, and grants by government organizations offer expansion opportunities for market competitors. For instance, in 2018, Bayer (Germany) launched the Medrad Centargo CT injection system for the CT injection segment. In July 2018, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics using CT and MRI imaging.
The contrast media injectors market is segmented on the basis of product type, application, and end user. By product type, the market is categorized into injector systems, accessories, and consumables. By application, it is fragmented into radiology, interventional cardiology, and interventional radiology. By end user, it is divided into hospitals, ambulatory surgical centers, and diagnostics imaging centers.
The key players operating in the global contrast media injectors market include Bayer HealthCare LLC; Bracco Imaging S.P.A, Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd., APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., and Medtron AG.
Contrast injectors are medical devices that are used to inject radio-opaque contrast media into the body to improve the visibility of tissues during a medical imaging treatment. With increasing technological sophistications every year, these contrast injectors have evolved from manual injectors with manifolds and stop-cocks to automated ones, delivering more precision and advantages. Autoinjectors are automated versions of injectors. In cardiac imaging, automated contrast media injectors are utilized to increase patient safety and image quality. These devices regulate contrast dosage, record how much is used, speed up injections to keep up with fast CT scanners, and warn of potential risks such as air embolisms or extravasations.
Major factors driving the growth of the contrast media injectors market include rising demand for minimally invasive surgical procedures. These devices assist the surgeons to accurately insert contrast agents with minimum human errors, thus increasing the accuracy and efficiency of surgical procedures. On the other hand, the high cost of contrast media injectors and consumables & accessories is restraining the growth of the market during the forecast period. Moreover, increasing prevalence of cancer and CVD is also responsible to boost the market growth.
Increasing investments, funds, new product launches, and grants by government organizations offer expansion opportunities for market competitors. For instance, in 2018, Bayer (Germany) launched the Medrad Centargo CT injection system for the CT injection segment. In July 2018, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics using CT and MRI imaging.
The contrast media injectors market is segmented on the basis of product type, application, and end user. By product type, the market is categorized into injector systems, accessories, and consumables. By application, it is fragmented into radiology, interventional cardiology, and interventional radiology. By end user, it is divided into hospitals, ambulatory surgical centers, and diagnostics imaging centers.
The key players operating in the global contrast media injectors market include Bayer HealthCare LLC; Bracco Imaging S.P.A, Guerbet Group, Ulrich GmbH & Co. KG, Nemoto Kyorindo Co., Ltd, Sino Medical-Device Technology Co., Ltd., APOLLO RT Co. Ltd., Shenzhen Anke High-tech Co. Ltd, Shenzen Seacrown Electromechanical Co Ltd., and Medtron AG.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global contrast media injectors market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global contrast media injectors market to predict the competitive environment across regions.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region & country-wise analysis is provided to understand the contrast media injectors market trends and dynamics.
KEY MARKET SEGMENTS
By Product Type
- Consumables
- Syringes
- Tubes
- Other Consumables
- Injector Systems
- CT Injectors
- MRI Injectors
- Angiography Injectors
- Accessories
By Application
- Radiology
- Interventional Cardiology
- Interventional Radiology
By End User
- Hospitals
- Ambulatory Surgery Centers
- Diagnostics Imaging Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
KEY MARKET PLAYERS
- Bayer Ag
- Bracco Imaging S.P.A
- Guerbet Group
- Ulrich GmbH & Co. KG
- Nemoto Kyorindo Co., Ltd
- Sino Medical-Device Technology Co., Ltd.
- APOLLO RT Co. Ltd.
- Shenzhen Anke High-tech Co. Ltd
- Shenzen Seacrown Electromechanical Co Ltd.
- Medtron AG RT Co. Ltd.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies, 2020
3.3. Porter’s five forces analysis
3.3.1. Top player positioning
3.4. Market dynamics
3.4.1. Drivers, restraints, and opportunity
3.4.2. Drivers
3.4.2.1. Increasing prevalence of cancer and cardiovascular diseases
3.4.2.2. Increase in unhealthy lifestyle
3.4.3. Restraints
3.4.3.1. High cost of contrast media injectors, consumables and accessories
3.4.4. Opportunity
3.4.4.1. Artificial intelligence to provide faster results
3.4.4.2. Increasing demand for MRI scans
3.5. Impact of COVID-19 on Contrast media injectors market
3.5.1. Overview
3.5.2. Impact analysis
CHAPTER 4: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Consumables
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by types
4.2.4.1. Syringes market size and forecast
4.2.4.2. Tubes market size and forecast
4.2.4.3. Other consumablesmarket size and forecast
4.3. Injector Systems
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.4. Injector Systems market size and forecast, by type
4.3.4.1. CT Injectors market size and forecast
4.3.4.2. MRI Injectors market size and forecast
4.3.4.3. Angiography Injectors market size and forecast
4.4. Accessories
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Radiology
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Interventional Radiology
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Interventional Cardiology
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: CONTRAST MEDIA INJECTORS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Diagnostic Imaging Centers
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Ambulatory surgery centers
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: CONTRAST MEDIA INJECTORS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key opportunities and forecast
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by product
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by end user
7.2.5.1. U. S.
7.2.5.1.1. U. S. market size and forecast, by product
7.2.5.1.2. U. S. market size and forecast, by application
7.2.5.1.3. U. S. market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Canada market size and forecast, by Product
7.2.5.2.2. Canada market size and forecast, by application
7.2.5.2.3. Canada market size and forecast, by end user
7.2.5.3. Mexico
7.2.5.3.1. Mexico market size and forecast, by product
7.2.5.3.2. Mexico market size and forecast, by application
7.2.5.3.3. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key opportunities and forecast
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by product
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by end user
7.3.5.1. Germany
7.3.5.1.1. Germany market size and forecast, by product
7.3.5.1.2. Germany market size and forecast, by application
7.3.5.1.3. Germany market size and forecast, by end user
7.3.5.2. France
7.3.5.2.1. France market size and forecast, by product
7.3.5.2.2. France market size and forecast, by application
7.3.5.2.3. France market size and forecast, by end user
7.3.5.3. UK
7.3.5.3.1. UK market size and forecast, by product
7.3.5.3.2. UK market size and forecast, by application
7.3.5.3.3. UK market size and forecast, by end user
7.3.5.4. Italy
7.3.5.4.1. Italy market size and forecast, by product
7.3.5.4.2. Italy market size and forecast, by application
7.3.5.4.3. Italy market size and forecast, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain market size and forecast, by Product
7.3.5.5.2. Spain market size and forecast, by application
7.3.5.5.3. Spain market size and forecast, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe market size and forecast, by Product
7.3.5.6.2. Rest of Europe market size and forecast, by application
7.3.5.6.3. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key opportunities and forecast
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by product
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by end user
7.4.5.1. Japan
7.4.5.1.1. Japan market size and forecast, by Product
7.4.5.1.2. Japan market size and forecast, by application
7.4.5.1.3. Japan market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. China market size and forecast, by product
7.4.5.2.2. China market size and forecast, by application
7.4.5.2.3. China market size and forecast, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia market size and forecast, by Product
7.4.5.3.2. Australia market size and forecast, by application
7.4.5.3.3. Australia market size and forecast, by end user
7.4.5.4. India
7.4.5.4.1. India market size and forecast, by Product
7.4.5.4.2. India market size and forecast, by application
7.4.5.4.3. India market size and forecast, by end user
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Rest of Asia-Pacific market size and forecast, by Product
7.4.5.5.2. Rest of Asia-Pacific market size and forecast, by application
7.4.5.5.3. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key opportunities and forecast
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by product
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by end user
7.5.5.1. Brazil
7.5.5.1.1. Brazil market size and forecast, by Product
7.5.5.1.2. Brazil market size and forecast, by application
7.5.5.1.3. Brazil market size and forecast, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia market size and forecast, by Product
7.5.5.2.2. Saudi Arabia market size and forecast, by application
7.5.5.2.3. Saudi Arabia market size and forecast, by end user
7.5.5.3. South Africa
7.5.5.3.1. South Africa market size and forecast, by Product
7.5.5.3.2. South Africa market size and forecast, by application
7.5.5.3.3. South Africa market size and forecast, by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA market size and forecast, by Product
7.5.5.4.2. Rest of LAMEA market size and forecast, by application
7.5.5.4.3. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. APOLLO RT CO. LTD.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Key strategic moves and developments
8.2. BAYER AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. BRACCO S. P. A.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. MEDTRON AG
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. NEMOTO KYORINDO CO., LTD.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.6. SHENZHEN ANKE HIGH-TECH CO., LTD.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. THE GUERBET GROUP
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. ULRICH GmbH & CO. KG
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developmentsLIST OF TABLES
TABLE 01. GLOBAL CONTRAST MEDIA INJECTORS MARKET REVENUE, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY REGION, 2020-2030($MILLION)
TABLE 03. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY APPLICATION, 2020-2030($MILLION)
TABLE 04. SYRINGES MARKET, 2020-2030 ($MILLION)
TABLE 05. TUBES MARKET, 2020-2030 ($MILLION)
TABLE 06. OTHER CONSUMABLES MARKET, 2020-2030 ($MILLION)
TABLE 07. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY REGION, 2020-2028($MILLION)
TABLE 08. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY APPLICATION, 2020-2030($MILLION)
TABLE 09. CT INJECTORS MARKET, 2020-2030 ($MILLION)
TABLE 10. MRI INJECTORS MARKET, 2020-2030 ($MILLION)
TABLE 11. ANGIOGRAPHY INJECTORS MARKET, 2020-2030 ($MILLION)
TABLE 12. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR ACCESSORIES, BY REGION, 2020-2030($MILLION)
TABLE 13. CONTRAST MEDIA INJECTORS MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 14. CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 15. INTERVENTIONAL RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 16. INTERVENTIONAL CARDIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 17. CONTRAST MEDIA INJECTORS MARKET REVENUE, BY END USER, 2020-2030($MILLION)
TABLE 18. CONTRAST MEDIA INJECTORS MARKET FOR HOSPITAL REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 19. CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 20. CONTRAST MEDIA INJECTORS MARKET FOR AMBULATORY SURGERY CENTERS REVENUE, BY REGION, 2020-2030($MILLION)
TABLE 21. CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 22. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 23. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 24. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 25. NORTH AMERICA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 26. U.S. CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 27. U.S. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 28. U.S. CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 29. CANADA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 30. CANADA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 31. CANADA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 32. MEXICO CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 33. MEXICO CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 34. MEXICO CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 35. EUROPE CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 36. EUROPE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 37. EUROPE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 38. EUROPE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 39. GERMANY CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 40. GERMANY CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 41. GERMANY CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 42. FRANCE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 43. FRANCE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 44. FRANCE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 45. UK CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 46. UK CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 47. UK CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 48. ITALY CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 49. ITALY CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 50. ITALY CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 51. SPAIN CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 52. SPAIN CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 53. SPAIN CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 54. REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 55. REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 56. REST OF EUROPE CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 57. ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 58. ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 59. ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 60. ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 61. JAPAN CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 62. JAPAN CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 63. JAPAN CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 64. CHINA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 65. CHINA. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 66. CHINA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 67. AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 68. AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 69. AUSTRALIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 70. INDIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 71. INDIA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 72. INDIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 73. REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 74. REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 75. REST OF ASIA-PACIFIC CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 76. LAMEA CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 77. LAMEA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 78. LAMEA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 79. LAMEA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 80. BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 81. BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 82. BRAZIL CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 83. SAUDI ARABIA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 84. SAUDI ARABIA. CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 85. SAUDI ARABIA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 86. SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 87. SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 88. SOUTH AFRICA CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 89. REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 90. REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 91. REST OF LAMEA CONTRAST MEDIA INJECTORS MARKET, BY END USER 2020-2030($MILLION)LIST OF FIGURES
FIGURE 01. GLOBAL CONTRAST MEDIA INJECTORS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENTS, 2018-2021*
FIGURE 04. TOP WINNING STRATEGIES, BY YEAR, 2018-2021*
FIGURE 05. TOP WINNING STRATEGIES: COMPANY , 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. MODERATE COMPETITIVE RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 13. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR CONSUMABLES, BY COUNTRY, 2020-2030(%)
FIGURE 14. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR INJECTOR SYSTEMS, BY COUNTRY, 2020-2030(%)
FIGURE 15. CONTRAST MEDIA INJECTORS MARKET REVENUE FOR ACCESSORIES, BY COUNTRY, 2020-2030(%)
FIGURE 16. RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 17. INTERVENTIONAL RADIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 18. INTERVENTIONAL CARDIOLOGY FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 19. HOSPITAL FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 20. DIAGNOSTIC IMAGING CENTERS FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020-2030(%)
FIGURE 21. AMBULATORY SURGERY CENTERS FOR CONTRAST MEDIA INJECTORS MARKET REVENUE, BY COUNTRY, 2020-2030(%)
Companies Mentioned
- Bayer HealthCare LLC; Bracco Imaging S.P.A
- Guerbet Group
- Ulrich GmbH & Co. KG
- Nemoto Kyorindo Co. Ltd
- Sino Medical-Device Technology Co. Ltd.
- APOLLO RT Co. Ltd.
- Shenzhen Anke High-tech Co. Ltd
- Shenzen Seacrown Electromechanical Co Ltd.
- Medtron AG.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
